Healthcare
Tarsus Pharmaceuticals, Inc.
TARS$74.24+3.46%
Price is delayed.
Add to Watchlist
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals makes medications for eye diseases. Their main product is XDEMVY, a liquid medicine that treats an eye condition caused by tiny mites living on the eyelid. They sell this medicine through pharmacies and hospitals. The company is also testing two other forms of the same active ingredient: a gel for a condition called ocular rosacea and a tablet for preventing Lyme disease.
Loading chart...
Members only
Full research is for ConvictionStocks members
Members read the rest of this page. Where we have it for this company, that is:
- What each number means, in plain English, with the Wall Street name where the two differ.
- A plain-English summary of the company.
- How many analysts cover it, and the count behind each rating.
- Recent news, dated.
Get the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Look up another company
Related Research
More Healthcare stocks to explore